NCT01517074View on ClinicalTrials.gov

Sirolimus Injections for Autoimmune Scleritis

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

5

Participants

Timeline

Start Date

January 31, 2012

Primary Completion Date

May 31, 2013

Study Completion Date

April 30, 2014

Conditions
Scleritis
Interventions
DRUG

Sirolimus

Subconjunctival injection

Trial Locations (1)

20892

National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda

All Listed Sponsors
lead

National Eye Institute (NEI)

NIH

NCT01517074 - Sirolimus Injections for Autoimmune Scleritis | Biotech Hunter | Biotech Hunter